Andson Biotech
ATLANTA, GA · Biotechnology · 9 employees
Andson Biotech is revolutionizing mass spec workflows for biopharma and beyond, driven by a mission to remove technical barriers so you can bring your most ambitious discoveries to life; with our cutting-edge DynaChip X1 platform, you can accelerate and simplify workflows, develop better and faster assays to streamline drug discovery, and reduce development time and costs—empowering you to push th
Funding history
- Series seed — $4.7M — Oct 2025
- Funding Round — $3.6M — Mar 2024
Recent signals
- Oct 22, 2025: Raised $4.7M in Series seed
- Mar 26, 2024: Raised $3.6M
See plans & pricing → Track Andson Biotech’s funding, hiring, and signals — with verified contacts — on Fundz.